EU Case Reports

[...] Generics claimed that the patent protecting levofloxacin, EP (UK) 0 206 283 ('the Patent') was invalid. [...] Generics attacked the SPC directly on the basis that the marketing authorisation covering levofloxacin and cited in the SPC application was not the first marketing authorisat...

Full description

Saved in:
Bibliographic Details
Published inJournal of generic medicines Vol. 7; no. 1; pp. 84 - 91
Main Authors Burdon, Michael, Singleton, Rebecca, Katzka, Catherine
Format Journal Article
LanguageEnglish
Published London, England SAGE Publications 01.01.2010
Sage Publications Ltd
Online AccessGet full text

Cover

More Information
Summary:[...] Generics claimed that the patent protecting levofloxacin, EP (UK) 0 206 283 ('the Patent') was invalid. [...] Generics attacked the SPC directly on the basis that the marketing authorisation covering levofloxacin and cited in the SPC application was not the first marketing authorisation for levofloxacin.
ISSN:1741-1343
1741-7090
DOI:10.1057/jgm.2009.41